BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NNC0662-0419 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of NNC0662-0419\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07184632-138@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261215
SUMMARY:NNC0662-0419: Phase 2 readout est. (NCT07184632)
DESCRIPTION:NNC0662-0419\, phase 2\, Obesity.\nStudy: A Research Study on H
 ow Well Different Doses of the Medicine NNC0662-0419 Help People Living Wi
 th Overweight or Obesity\nEstimated primary completion: 14 December 2026. 
 This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and
  it can move.\nDrug page: https://assetmemo.bio/drug/nnc0662-0419#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT07184632
URL:https://assetmemo.bio/drug/nnc0662-0419#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07525791-138@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20270502
DTEND;VALUE=DATE:20270503
SUMMARY:NNC0662-0419: Phase 1 readout est. (NCT07525791)
DESCRIPTION:NNC0662-0419\, phase 1\, Obesity.\nStudy: A Research Study Look
 ing Into How NNC0662-0419 Works With Birth Control Pills and Emptying of t
 he Stomach in Women Not Able to Become Pregnant With Excess Body Weight\nE
 stimated primary completion: 2 May 2027. This is a ClinicalTrials.gov esti
 mate\, not a confirmed readout date\, and it can move.\nDrug page: https:/
 /assetmemo.bio/drug/nnc0662-0419#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07525791
URL:https://assetmemo.bio/drug/nnc0662-0419#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07639021-138@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20270614
DTEND;VALUE=DATE:20270615
SUMMARY:NNC0662-0419: Phase 2 readout est. (NCT07639021)
DESCRIPTION:NNC0662-0419\, phase 2\, Obesity.\nStudy: A Research Study Comp
 aring Different Ways of Increasing the Dose of NNC0662-0419 in Participant
 s With Obesity\nEstimated primary completion: 14 June 2027. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/nnc0662-0419#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07639021
URL:https://assetmemo.bio/drug/nnc0662-0419#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07415954-138@assetmemo.bio
DTSTAMP:20261121T005729Z
DTSTART;VALUE=DATE:20270903
DTEND;VALUE=DATE:20270904
SUMMARY:NNC0662-0419: Phase 2 readout est. (NCT07415954)
DESCRIPTION:NNC0662-0419\, phase 2\, Type 2 Diabetes.\nStudy: A Research St
 udy Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower 
 Blood Sugar in People With Type 2 Diabetes\nEstimated primary completion: 
 3 September 2027. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/nnc
 0662-0419#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT07415954
URL:https://assetmemo.bio/drug/nnc0662-0419#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
